Drugs / Flu-M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05089123 | Mar → May 2020 | influenza | St. Petersburg Research Institute of Vaccines and Sera | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flu-M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05089123 ↗ |
| Modality | Vaccine | “Flu-M inactivated split influenza vaccine” NCT05089123 ↗ |
| Route | Intramuscular | “solution for intramuscular injection, 0.5 mL, intramuscularly” NCT05089123 ↗ |